Auriga Laboratories, Inc. Announces Development Agreement With Balchem Corporation For Rapid Dissolve Drug Products
NORCROSS, Ga.--(BUSINESS WIRE)--Aug. 8, 2006--Auriga Laboratories(TM), Inc. (OTCBB:ARGA - News), a specialty pharmaceutical company and marketer of the Extendryl® family of products, announces the execution of a development agreement with Balchem Corporation (AMEX:BCP - News) to develop a set of novel combination medicines in the rapid dissolve format.